Skip to main content
Top
Published in: Diabetologia 6/2018

Open Access 01-06-2018 | Short Communication

Interplay between genetic predisposition, macronutrient intake and type 2 diabetes incidence: analysis within EPIC-InterAct across eight European countries

Authors: Sherly X. Li, Fumiaki Imamura, Matthias B. Schulze, Jusheng Zheng, Zheng Ye, Antonio Agudo, Eva Ardanaz, Dagfinn Aune, Heiner Boeing, Miren Dorronsoro, Courtney Dow, Guy Fagherazzi, Sara Grioni, Marc J. Gunter, José María Huerta, Daniel B. Ibsen, Marianne Uhre Jakobsen, Rudolf Kaaks, Timothy J. Key, Kay-Tee Khaw, Cecilie Kyrø, Francesca Romana Mancini, Elena Molina-Portillo, Neil Murphy, Peter M. Nilsson, N. Charlotte Onland-Moret, Domenico Palli, Salvatore Panico, Alaitz Poveda, J. Ramón Quirós, Fulvio Ricceri, Ivonne Sluijs, Annemieke M. W. Spijkerman, Anne Tjonneland, Rosario Tumino, Anna Winkvist, Claudia Langenberg, Stephen J. Sharp, Elio Riboli, Robert A. Scott, Nita G. Forouhi, Nicholas J. Wareham

Published in: Diabetologia | Issue 6/2018

Login to get access

Abstract

Aims/hypothesis

Gene–macronutrient interactions may contribute to the development of type 2 diabetes but research evidence to date is inconclusive. We aimed to increase our understanding of the aetiology of type 2 diabetes by investigating potential interactions between genes and macronutrient intake and their association with the incidence of type 2 diabetes.

Methods

We investigated the influence of interactions between genetic risk scores (GRSs) for type 2 diabetes, insulin resistance and BMI and macronutrient intake on the development of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct, a prospective case-cohort study across eight European countries (N = 21,900 with 9742 incident type 2 diabetes cases). Macronutrient intake was estimated from diets reported in questionnaires, including proportion of energy derived from total carbohydrate, protein, fat, plant and animal protein, saturated, monounsaturated and polyunsaturated fat and dietary fibre. Using multivariable-adjusted Cox regression, we estimated country-specific interaction results on the multiplicative scale, using random-effects meta-analysis. Secondary analysis used isocaloric macronutrient substitution.

Results

No interactions were identified between any of the three GRSs and any macronutrient intake, with low-to-moderate heterogeneity between countries (I2 range 0–51.6%). Results were similar using isocaloric macronutrient substitution analyses and when weighted and unweighted GRSs and individual SNPs were examined.

Conclusions/interpretation

Genetic susceptibility to type 2 diabetes, insulin resistance and BMI did not modify the association between macronutrient intake and incident type 2 diabetes. This suggests that macronutrient intake recommendations to prevent type 2 diabetes do not need to account for differences in genetic predisposition to these three metabolic conditions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Li SX, Imamura F, Ye Z et al (2017) Interaction between genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from EPIC- InterAct. Am J Clin Nutr 106:263–275CrossRefPubMedPubMedCentral Li SX, Imamura F, Ye Z et al (2017) Interaction between genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from EPIC- InterAct. Am J Clin Nutr 106:263–275CrossRefPubMedPubMedCentral
2.
go back to reference Langenberg C, Sharp S, Forouhi NG et al (2011) Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 54:2272–2282CrossRefPubMedPubMedCentral Langenberg C, Sharp S, Forouhi NG et al (2011) Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 54:2272–2282CrossRefPubMedPubMedCentral
3.
go back to reference Morris AP, Voight BF, Teslovich TM et al (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44:981–990CrossRefPubMedPubMedCentral Morris AP, Voight BF, Teslovich TM et al (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44:981–990CrossRefPubMedPubMedCentral
5.
go back to reference Lotta L, Gulati P, Day FR et al (2016) Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet 49:17–26CrossRefPubMedPubMedCentral Lotta L, Gulati P, Day FR et al (2016) Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet 49:17–26CrossRefPubMedPubMedCentral
6.
go back to reference Barlow WE, Ichikawa L, Rosner D, Izumi S (1999) Analysis of case-cohort designs. J Clin Epidemiol 52:1165–1172CrossRefPubMed Barlow WE, Ichikawa L, Rosner D, Izumi S (1999) Analysis of case-cohort designs. J Clin Epidemiol 52:1165–1172CrossRefPubMed
7.
go back to reference Sluijs I, Beulens JWJ, Van Der Schouw YT et al (2013) Dietary glycemic index, glycemic load, and digestible carbohydrate intake are not associated with risk of type 2 diabetes in eight European countries. J Nutr 143:93–99CrossRefPubMed Sluijs I, Beulens JWJ, Van Der Schouw YT et al (2013) Dietary glycemic index, glycemic load, and digestible carbohydrate intake are not associated with risk of type 2 diabetes in eight European countries. J Nutr 143:93–99CrossRefPubMed
8.
go back to reference van Nielen M, Feskens EJM, Mensink M et al (2014) Dietary protein intake and incidence of type 2 diabetes in Europe: the EPIC-InterAct Case-Cohort Study. Diabetes Care 37:1854–1862CrossRefPubMed van Nielen M, Feskens EJM, Mensink M et al (2014) Dietary protein intake and incidence of type 2 diabetes in Europe: the EPIC-InterAct Case-Cohort Study. Diabetes Care 37:1854–1862CrossRefPubMed
9.
go back to reference The InterAct Consortium (2015) Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-InterAct Study and a meta-analysis of prospective studies. Diabetologia 58:1394–1408CrossRefPubMedCentral The InterAct Consortium (2015) Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-InterAct Study and a meta-analysis of prospective studies. Diabetologia 58:1394–1408CrossRefPubMedCentral
10.
go back to reference Villegas R, Goodloe RJ, McClellan BE, Boston J, Crawford DC (2014) Gene-carbohydrate and gene-fiber interactions and type 2 diabetes in diverse populations from the National Health and Nutrition Examination Surveys (NHANES) as part of the epidemiologic architecture for genes linked to environment (EAGLE) study. BMC Genet 15:1–8CrossRef Villegas R, Goodloe RJ, McClellan BE, Boston J, Crawford DC (2014) Gene-carbohydrate and gene-fiber interactions and type 2 diabetes in diverse populations from the National Health and Nutrition Examination Surveys (NHANES) as part of the epidemiologic architecture for genes linked to environment (EAGLE) study. BMC Genet 15:1–8CrossRef
Metadata
Title
Interplay between genetic predisposition, macronutrient intake and type 2 diabetes incidence: analysis within EPIC-InterAct across eight European countries
Authors
Sherly X. Li
Fumiaki Imamura
Matthias B. Schulze
Jusheng Zheng
Zheng Ye
Antonio Agudo
Eva Ardanaz
Dagfinn Aune
Heiner Boeing
Miren Dorronsoro
Courtney Dow
Guy Fagherazzi
Sara Grioni
Marc J. Gunter
José María Huerta
Daniel B. Ibsen
Marianne Uhre Jakobsen
Rudolf Kaaks
Timothy J. Key
Kay-Tee Khaw
Cecilie Kyrø
Francesca Romana Mancini
Elena Molina-Portillo
Neil Murphy
Peter M. Nilsson
N. Charlotte Onland-Moret
Domenico Palli
Salvatore Panico
Alaitz Poveda
J. Ramón Quirós
Fulvio Ricceri
Ivonne Sluijs
Annemieke M. W. Spijkerman
Anne Tjonneland
Rosario Tumino
Anna Winkvist
Claudia Langenberg
Stephen J. Sharp
Elio Riboli
Robert A. Scott
Nita G. Forouhi
Nicholas J. Wareham
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 6/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4586-2

Other articles of this Issue 6/2018

Diabetologia 6/2018 Go to the issue

Up Front

Up front

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.